All Metrics
WST Valuation Metrics
WST Stock Price Metrics
WST Dividend Metrics
WST Growth Rate Metrics
WST Discounted Cash Flow Metrics
| Fair Value Price | $94.19 |
| Margin of Safety | (73.15%) |
WST Revenue Metrics
WST PE Ratio Metrics
| PE Ratio | 46.84 |
| PE Ratio Avg TTM | 38.82 |
| PE Ratio Avg 3Y | 43.21 |
| Current VS TTM Avg | +20.66% |
| Current VS 3Y Avg | +8.39% |
| Current VS 5Y Avg | +7.60% |
WST PS Ratio Metrics
| PS Ratio | 7.89 |
| PS Ratio Avg TTM | 6.36 |
| PS Ratio Avg 3Y | 7.65 |
| Current VS TTM Avg | +24.08% |
| Current VS 3Y Avg | +3.14% |
| Current VS 5Y Avg | -6.02% |
WST PB Ratio Metrics
| PB Ratio | 8.49 |
| PB Ratio Avg TTM | 6.35 |
| PB Ratio Avg 3Y | 7.99 |
| Current VS TTM Avg | +33.75% |
| Current VS 3Y Avg | +6.25% |
| Current VS 5Y Avg | -3.66% |
WST Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 55.46 |
| PFCF Ratio Avg TTM | 50.99 |
| PFCF Ratio Avg 3Y | 60.14 |
| Current VS TTM Avg | +8.78% |
| Current VS 3Y Avg | -7.79% |
| Current VS 5Y Avg | -11.84% |
WST Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.11 |
| Debt/Equity Ratio Avg TTM | 0.10 |
| Debt/Equity Ratio Avg 3Y | 0.11 |
| Current VS TTM Avg | +1.49% |
| Current VS 3Y Avg | -3.21% |
| Current VS 5Y Avg | -13.09% |
WST PEG Ratio Metrics
| PEG Ratio | 33.99 |
| PEG Ratio Avg TTM | - |
| PEG Ratio Avg 3Y | 32.78 |
| Current VS TTM Avg | - |
| Current VS 3Y Avg | +3.69% |
| Current VS 5Y Avg | +101.30% |
WST FCF Yield
| FCF Yield | 1.80% |
| FCF Yield Avg TTM | 1.95% |
| FCF Yield Avg 3Y | 1.69% |
| Current VS TTM Avg | -7.61% |
| Current VS 3Y Avg | +6.51% |
| Current VS 5Y Avg | +11.51% |
WST Earnings Yield
| Earnings Yield | 2.13% |
| Earnings Yield Avg TTM | 2.59% |
| Earnings Yield Avg 3Y | 2.37% |
| Current VS TTM Avg | -17.76% |
| Current VS 3Y Avg | -10.24% |
| Current VS 5Y Avg | -11.47% |
WST EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 37.86 |
| Ev/Ebit Ratio Avg TTM | 30.14 |
| Ev/Ebit Ratio Avg 3Y | 33.98 |
| Current VS TTM Avg | +25.63% |
| Current VS 3Y Avg | +11.41% |
| Current VS 5Y Avg | +8.76% |
WST EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 29.94 |
| Ev/Ebitda Ratio Avg TTM | 23.83 |
| Ev/Ebitda Ratio Avg 3Y | 27.65 |
| Current VS TTM Avg | +25.66% |
| Current VS 3Y Avg | +8.29% |
| Current VS 5Y Avg | +3.37% |
WST EV/Assets Ratio Metrics
| Ev/Assets Ratio | 6.13 |
| Ev/Assets Ratio Avg TTM | 4.64 |
| Ev/Assets Ratio Avg 3Y | 5.88 |
| Current VS TTM Avg | +32.19% |
| Current VS 3Y Avg | +4.30% |
| Current VS 5Y Avg | -6.77% |
WST EV/Sales Ratio Metrics
| Ev/Sales Ratio | 7.82 |
| Ev/Sales Ratio Avg TTM | 6.26 |
| Ev/Sales Ratio Avg 3Y | 7.54 |
| Current VS TTM Avg | +24.82% |
| Current VS 3Y Avg | +3.69% |
| Current VS 5Y Avg | -5.49% |
WST Current Ratio Metrics
| Current Ratio | 2.71 |
| Current Ratio Avg TTM | 2.83 |
| Current Ratio Avg 3Y | 2.83 |
| Current VS TTM Avg | -4.21% |
| Current VS 3Y Avg | -4.11% |
| Current VS 5Y Avg | -7.52% |
WST Quick Ratio Metrics
| Quick Ratio | 2.04 |
| Quick Ratio Avg TTM | 2.13 |
| Quick Ratio Avg 3Y | 2.20 |
| Current VS TTM Avg | -4.50% |
| Current VS 3Y Avg | -7.47% |
| Current VS 5Y Avg | -8.37% |
WST ROIC Metrics
| ROIC | 13.62% |
| ROIC Avg 3Y | 16.90% |
| ROIC Avg 5Y | 17.70% |
| Current VS 3Y Avg | -19.42% |
| Current VS 5Y Avg | -23.04% |
| Current VS 10Y Avg | -4.81% |
WST Return on Assets Metrics
| ROA | 11.56% |
| ROA Avg TTM | 12.54% |
| ROA Avg 3Y | 14.20% |
| Current VS TTM Avg | -7.81% |
| Current VS 3Y Avg | -18.56% |
| Current VS 5Y Avg | -22.19% |
WST Return on Equity Metrics
| ROE | 15.54% |
| ROE Avg TTM | 16.95% |
| ROE Avg 3Y | 19.08% |
| Current VS TTM Avg | -8.35% |
| Current VS 3Y Avg | -18.56% |
| Current VS 5Y Avg | -24.40% |
WST Net Profit Margin Metrics
| Net Profit Margin | 16.43% |
| Net Profit Margin Avg TTM | 16.06% |
| Net Profit Margin Avg 3Y | 17.99% |
| Current VS TTM Avg | +2.28% |
| Current VS 3Y Avg | -8.69% |
| Current VS 5Y Avg | -14.38% |
Last Updated: Saturday, June 27, 2026
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Eric Green